Breaking News

InterMune Names Chief Business Officer

February 15, 2013

Nolan to build U.S. commercial operations

Sean P. Nolan has been appointed executive vice president and chief business officer at InterMune, Inc. In this newly created position, Mr. Nolan will lead the establishment of InterMune's U.S. commercial, business development and global marketing groups. He will also oversee Canadian operations and the company's manufacturing operations and supply chain management. Mr. Nolan will report to Dan Welch, chairman, chief executive officer and president of InterMune.
Mr. Nolan joins the company from Reata Pharmaceuticals, where he most recently served as vice president and chief commercial officer and built a commercial operation to support the company's lead product.
Mr. Welch said, "Sean will play a key role in InterMune's future as our Esbriet sales continue to grow globally, we move closer to the anticipated approval and launch of Esbriet [a treatment for idiopathic pulmonary fibrosis] in the U.S. and as we prepare to develop our business. I am confident that Sean will provide the broad and deep commercial and business experience, energy and drive that are essential during this exciting period of growth and change for our company."

Related Packaging:

  • Packaging Equipment Technology Preview

    Packaging Equipment Technology Preview

    February 15, 2017
    Today’s complex drug products present challenges; the latest equipment capabilities help overcome them

  • The Good, the Bad, and the Donald

    The Good, the Bad, and the Donald

    January 31, 2017
    Orphan drugs, CMO continuous manufacturing and developing world sales offer biggest revenue opportunities

  • Predictive Analytics and the Future of RBM

    Rajneesh Patil, Senior Director, RBM and Analytics, QuintilesIMS||January 23, 2017
    How advances in Risk-Based Monitoring will enable a more proactive approach to identify and mitigate potential risks